rs61733199

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021957.4(GYS2):​c.1636A>G​(p.Thr546Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0173 in 1,605,770 control chromosomes in the GnomAD database, including 312 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T546T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.014 ( 22 hom., cov: 32)
Exomes 𝑓: 0.018 ( 290 hom. )

Consequence

GYS2
NM_021957.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.595

Publications

10 publications found
Variant links:
Genes affected
GYS2 (HGNC:4707): (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
GYS2 Gene-Disease associations (from GenCC):
  • glycogen storage disorder due to hepatic glycogen synthase deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0037274063).
BP6
Variant 12-21542505-T-C is Benign according to our data. Variant chr12-21542505-T-C is described in ClinVar as Benign. ClinVar VariationId is 137526.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0144 (2199/152346) while in subpopulation NFE AF = 0.019 (1295/68022). AF 95% confidence interval is 0.0182. There are 22 homozygotes in GnomAd4. There are 1173 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GYS2NM_021957.4 linkc.1636A>G p.Thr546Ala missense_variant Exon 13 of 16 ENST00000261195.3 NP_068776.2 P54840
GYS2XM_024448960.2 linkc.1636A>G p.Thr546Ala missense_variant Exon 13 of 17 XP_024304728.1
GYS2XM_006719063.4 linkc.1405A>G p.Thr469Ala missense_variant Exon 12 of 15 XP_006719126.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GYS2ENST00000261195.3 linkc.1636A>G p.Thr546Ala missense_variant Exon 13 of 16 1 NM_021957.4 ENSP00000261195.2 P54840
ENSG00000285854ENST00000647960.1 linkn.*1638A>G non_coding_transcript_exon_variant Exon 20 of 23 ENSP00000497202.1 A0A3B3IS95
ENSG00000285854ENST00000647960.1 linkn.*1638A>G 3_prime_UTR_variant Exon 20 of 23 ENSP00000497202.1 A0A3B3IS95

Frequencies

GnomAD3 genomes
AF:
0.0144
AC:
2199
AN:
152228
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00309
Gnomad AMI
AF:
0.0417
Gnomad AMR
AF:
0.00982
Gnomad ASJ
AF:
0.0182
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.0454
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0190
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.0160
AC:
4020
AN:
251344
AF XY:
0.0161
show subpopulations
Gnomad AFR exome
AF:
0.00295
Gnomad AMR exome
AF:
0.00928
Gnomad ASJ exome
AF:
0.0215
Gnomad EAS exome
AF:
0.000598
Gnomad FIN exome
AF:
0.0474
Gnomad NFE exome
AF:
0.0193
Gnomad OTH exome
AF:
0.0160
GnomAD4 exome
AF:
0.0176
AC:
25533
AN:
1453424
Hom.:
290
Cov.:
29
AF XY:
0.0170
AC XY:
12335
AN XY:
723628
show subpopulations
African (AFR)
AF:
0.00255
AC:
85
AN:
33270
American (AMR)
AF:
0.00919
AC:
411
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.0197
AC:
513
AN:
26076
East Asian (EAS)
AF:
0.00202
AC:
80
AN:
39672
South Asian (SAS)
AF:
0.00333
AC:
287
AN:
86126
European-Finnish (FIN)
AF:
0.0462
AC:
2466
AN:
53400
Middle Eastern (MID)
AF:
0.00313
AC:
18
AN:
5756
European-Non Finnish (NFE)
AF:
0.0188
AC:
20763
AN:
1104298
Other (OTH)
AF:
0.0151
AC:
910
AN:
60120
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
1145
2291
3436
4582
5727
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
752
1504
2256
3008
3760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0144
AC:
2199
AN:
152346
Hom.:
22
Cov.:
32
AF XY:
0.0157
AC XY:
1173
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.00308
AC:
128
AN:
41588
American (AMR)
AF:
0.00980
AC:
150
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0182
AC:
63
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5192
South Asian (SAS)
AF:
0.00248
AC:
12
AN:
4834
European-Finnish (FIN)
AF:
0.0454
AC:
482
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0190
AC:
1295
AN:
68022
Other (OTH)
AF:
0.0118
AC:
25
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
114
228
343
457
571
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0170
Hom.:
105
Bravo
AF:
0.0120
TwinsUK
AF:
0.0194
AC:
72
ALSPAC
AF:
0.0174
AC:
67
ESP6500AA
AF:
0.00363
AC:
16
ESP6500EA
AF:
0.0206
AC:
177
ExAC
AF:
0.0150
AC:
1818
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0153
EpiControl
AF:
0.0154

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disorder due to hepatic glycogen synthase deficiency Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 08, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 07, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
14
DANN
Benign
0.95
DEOGEN2
Benign
0.19
T
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.62
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.70
T
MetaRNN
Benign
0.0037
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.29
N
PhyloP100
0.59
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.89
N
REVEL
Benign
0.023
Sift
Benign
0.38
T
Sift4G
Benign
0.80
T
Polyphen
0.0
B
Vest4
0.066
MPC
0.12
ClinPred
0.0020
T
GERP RS
0.30
Varity_R
0.068
gMVP
0.23
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61733199; hg19: chr12-21695439; API